Log in
Enquire now
‌

US Patent 7682828 Methods for reprogramming somatic cells

OverviewStructured DataIssuesContributors

Contents

Is a
Patent
Patent
0

Patent attributes

Patent Jurisdiction
United States Patent and Trademark Office
United States Patent and Trademark Office
0
Patent Number
76828280
Patent Inventor Names
Konrad Hochedlinger0
Rudolf Jaenisch0
Date of Patent
March 23, 2010
0
Patent Application Number
109971460
Date Filed
November 24, 2004
0
Patent Citations Received
‌
US Patent 12006508 Methods and products for expressing proteins in cells
0
‌
US Patent 11851670 Nucleic acid constructs encoding reprogramming factors linked by self-cleaving peptides
0
‌
US Patent 11884915 Guide RNAs with chemical modification for prime editing
0
‌
US Patent 11904023 Nucleic acid products and methods of administration thereof
0
‌
US Patent 11987815 Methods for reprogramming somatic cells
0
‌
US Patent 11998570 Mammalian lung spheroids and lung spheroid cells and uses thereof
0
‌
US Patent 11708586 Methods and products for transfecting cells
0
Patent Primary Examiner
‌
Thaian N. Ton
0
Patent abstract

The invention provides methods for reprogramming somatic cells to generate multipotent or pluripotent cells. Such methods are useful for a variety of purposes, including treating or preventing a medical condition in an individual. The invention further provides methods for identifying an agent that reprograms somatic cells to a less differentiated state.

Timeline

No Timeline data yet.

Further Resources

Title
Author
Link
Type
Date
No Further Resources data yet.

References

Find more entities like US Patent 7682828 Methods for reprogramming somatic cells

Use the Golden Query Tool to find similar entities by any field in the Knowledge Graph, including industry, location, and more.
Open Query Tool
Access by API
Golden Query Tool
Golden logo

Company

  • Home
  • Press & Media
  • Blog
  • Careers
  • WE'RE HIRING

Products

  • Knowledge Graph
  • Query Tool
  • Data Requests
  • Knowledge Storage
  • API
  • Pricing
  • Enterprise
  • ChatGPT Plugin

Legal

  • Terms of Service
  • Enterprise Terms of Service
  • Privacy Policy

Help

  • Help center
  • API Documentation
  • Contact Us
By using this site, you agree to our Terms of Service.